Business Description
MediciNova Inc
NAICS : 325412
SIC : 2834
ISIN : US58468P2065
Compare
Compare
Traded in other countries / regions
4875.JapanMNOV.USARMN.Germany IPO Date
2006-12-07Description
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 236.11 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | 18.1 | |||||
| 3-Year FCF Growth Rate | 14.7 | |||||
| 3-Year Book Growth Rate | -7.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.37 | |||||
| 9-Day RSI | 29.35 | |||||
| 14-Day RSI | 36.47 | |||||
| 6-1 Month Momentum % | -29.9 | |||||
| 12-1 Month Momentum % | -36.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.61 | |||||
| Quick Ratio | 15.61 | |||||
| Cash Ratio | 15.55 | |||||
| Days Sales Outstanding | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | -0.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -990 | |||||
| Net Margin % | -857.2 | |||||
| FCF Margin % | -743.1 | |||||
| ROE % | -12.98 | |||||
| ROA % | -12.3 | |||||
| ROIC % | -62.88 | |||||
| ROC (Joel Greenblatt) % | -1495.47 | |||||
| ROCE % | -14.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 65.5 | |||||
| PB Ratio | 1.03 | |||||
| Price-to-Tangible-Book | 1.34 | |||||
| EV-to-EBIT | -1.36 | |||||
| EV-to-EBITDA | -1.36 | |||||
| EV-to-Revenue | 13.47 | |||||
| EV-to-FCF | -1.81 | |||||
| Price-to-Net-Current-Asset-Value | 1.36 | |||||
| Price-to-Net-Cash | 1.36 | |||||
| Earnings Yield (Greenblatt) % | -73.53 | |||||
| FCF Yield % | -11.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MNOV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MediciNova Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1 | ||
| EPS (TTM) ($) | -0.17 | ||
| Beta | 0.26 | ||
| Volatility % | 27.24 | ||
| 14-Day RSI | 36.47 | ||
| 14-Day ATR ($) | 0.070819 | ||
| 20-Day SMA ($) | 1.44975 | ||
| 12-1 Month Momentum % | -36.45 | ||
| 52-Week Range ($) | 1.26 - 2.66 | ||
| Shares Outstanding (Mil) | 49.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MediciNova Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MediciNova Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MediciNova Inc Frequently Asked Questions
What is MediciNova Inc(MNOV)'s stock price today?
The current price of MNOV is $1.31. The 52 week high of MNOV is $2.66 and 52 week low is $1.26.
When is next earnings date of MediciNova Inc(MNOV)?
The next earnings date of MediciNova Inc(MNOV) is 2024-05-10 Est..
Does MediciNova Inc(MNOV) pay dividends? If so, how much?
MediciNova Inc(MNOV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers